Quick Summary
Ribaxa+ 100mg Tablet 10's
Last updated on 20 Apr 2026 | 04:50 AM (IST)
₹938
MRP: ₹1562.44
(You Save ₹624.44)
10 TABLET(s) IN A STRIP
40% OFF
₹938
MRP: ₹1,562.44
Inclusive of all taxes
40% Off
Product Discontinued
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Olzapar 100mg Tablet
DELARC PHARMACE...
₹ 105.48/tablet
13% costlier
Viaparib 100mg Tablet
MYLAN PHARMACEU...
₹ 108.63/tablet
16% costlier
Zeparib 100mg Tablet
ZEE LABORATORIE...
₹ 109.40/tablet
17% costlier
Canrib 100mg Tablet
ADLEY FORMULATI...
₹ 114.85/tablet
23% costlier


Introduction
Ribaxa+ 100mg Tablet 10's contains Olaparib, a medication from the PARP inhibitor class (Poly ADP-ribose polymerase inhibitors). It plays an important role in managing certain types of cancer like prostate cancer and metastatic pancreatic cancer. Ribaxa+ 100mg Tablet 10's helps by targeting and blocking the PARP enzyme that cancer cells use to repair their DNA, making them more likely to die.
Your doctor may prescribe Ribaxa+ 100mg Tablet 10's alone or along with other anti-cancer medicines depending on your health condition. Before starting, inform your doctor if you have any pre-existing issues like liver, lung, heart, or kidney diseases.
It’s not recommended during pregnancy and breastfeeding as it may cause harm to the baby. For women of reproductive age, a pregnancy test is usually advised before beginning treatment. For men, sperm donation should be avoided for at least three months after completing therapy.
If you are searching for Ribaxa+ 100mg Tablet 10's alternatives, always speak to your doctor before making any changes.
Uses
Ribaxa+ 100mg Tablet 10's uses include:
-
Treatment of prostate cancer
-
Treatment of metastatic pancreatic cancer
-
Used as maintenance therapy after chemotherapy in some cancers
If you’re wondering about ibyra 150 uses, your oncologist will guide you based on your specific cancer type and stage.
How Ribaxa+ 100mg Tablet 10's works
Ribaxa+ 100mg Tablet 10's works by inhibiting the PARP enzyme, a key factor involved in DNA repair in cancer cells. By blocking this repair mechanism, Ribaxa+ 100mg Tablet 10's increases cancer cell death, especially in tumors that already have impaired DNA repair ability.
This targeted action slows cancer progression and improves survival outcomes in eligible patients.
Interaction of Ribaxa+ 100mg Tablet 10's with Other Drugs
Before starting Ribaxa+ 100mg Tablet 10's, inform your doctor about:
-
All prescription and non-prescription drugs
-
Any vitamin supplements or herbal products
Certain medicines may alter Ibyra 150 composition and increase the risk of side effects or reduce its effectiveness.
Storage conditions
-
Store Ribaxa+ 100mg Tablet 10's at room temperature between 20°C to 25°C
-
Keep it in the original packaging
-
Protect from moisture, heat, and direct sunlight
-
Keep out of reach of children
If you miss a dose, skip it if it’s close to your next scheduled dose. Do not double up.
How to take Ribaxa+ 100mg Tablet 10's
- Dosage and duration will be decided by your oncologist
-
Swallow the tablet whole with water
-
Do not crush, chew, or break the tablet
-
Take it with or without food, preferably at the same time each day
Your doctor may adjust your dose depending on your response and tolerance.
Safety Advices
Pregnancy
Ribaxa+ 100mg Tablet 10's may harm your unborn baby. Inform your doctor if you are pregnant, planning pregnancy, or think you could be pregnant.
Breast Feeding
Avoid breastfeeding during and for at least one month after completing Ribaxa+ 100mg Tablet 10's therapy, as it may pass into breast milk.
Lungs
Tell your doctor if you have any lung-related diseases as Ribaxa+ 100mg Tablet 10's may affect lung function.
Liver
If you have liver problems, inform your doctor before starting Ribaxa+ 100mg Tablet 10's.
Alcohol
The interaction between Ribaxa+ 100mg Tablet 10's and alcohol is not clearly established. It’s best to ask your doctor.
Driving
Ribaxa+ 100mg Tablet 10's can cause dizziness, fatigue, or weakness. Avoid driving or using heavy machinery if you feel unwell.
Side Effects
Like all medicines, Ribaxa+ 100mg Tablet 10's may cause side effects, but not everyone gets them.
Common Side Effects:
-
Shortness of breath
-
Nausea
-
Vomiting
-
Fatigue
-
Indigestion
-
Loss of appetite
-
Dizziness
-
Diarrhea
-
Headache
Serious Side Effects:
-
Neutropenia (low neutrophil count)
-
Acute myeloid leukemia (rare)
-
Leukopenia (low white blood cells)
-
Thrombocytopenia (low platelets)
-
Lung-related issues like inflammation or scarring
If you experience any severe or unusual symptoms, contact your doctor immediately.
Expert Tips
-
Take Ribaxa+ 100mg Tablet 10's at the same time daily for better treatment consistency.
-
Stay hydrated and eat a balanced diet to help manage side effects.
-
Avoid sun exposure; use sunscreen with SPF 50 or more.
-
Refrain from consuming grapefruit or grapefruit juice, as it may raise Ribaxa+ 100mg Tablet 10's levels in your blood.
-
Regular blood tests are essential to monitor your blood counts and organ function during treatment.
FAQs
Q1.
What is Ribaxa+ 100mg Tablet 10's used for?
Ibyra 150 uses include treating prostate cancer and metastatic pancreatic cancer, often after chemotherapy.
Q2.
Can Ribaxa+ 100mg Tablet 10's be taken during pregnancy or breastfeeding?
No, it’s not recommended during pregnancy or breastfeeding due to potential harm to the baby.
Q3.
Are there any dietary restrictions while using Ribaxa+ 100mg Tablet 10's?
Avoid grapefruit products as they can affect Ribaxa+ 100mg Tablet 10's levels in your blood.
Q4.
Can Ribaxa+ 100mg Tablet 10's cause low blood cell counts?
Yes, Ribaxa+ 100mg Tablet 10's may lower your red and white blood cells and platelets. Regular monitoring is advised.
Q5.
Are there any alternatives to Ribaxa+ 100mg Tablet 10's?
If Ribaxa+ 100mg Tablet 10's alternatives are needed, your oncologist will suggest the most suitable options based on your condition and treatment goals.
Fact Box
|
Molecule Name |
Olaparib |
|
Therapeutic class |
Antineoplastic agents |
|
Pharmacological class |
Poly Adenosine Diphosphate-Ribose Polymerase (PARP) inhibitor |
|
Indications |
1. Treatment of Prostate cancer 2. Metastatic Pancreatic cancer |
References
-
Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
-
AstraZeneca UK Limited, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
- AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Vikas B S
Pharm D

Reviewed By
Dr. Abhishaanth Prabu
MBBS
Last updated : 20 Apr 2026 | 04:50 AM (IST)

Want to know more?
Read Our Editorial Policy









